Moderna, Inc.
MRNA
$27.12
$0.903.43%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 50.52% | 43.75% | 24.46% | 35.83% | -586.08% |
| Total Depreciation and Amortization | -60.61% | -66.84% | -69.57% | -33.67% | 45.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -46.16% | -24.76% | 55.94% | -151.25% | 294.74% |
| Change in Net Operating Assets | -142.63% | -118.44% | -111.32% | -214.04% | 188.80% |
| Cash from Operations | 16.78% | -5.90% | 3.66% | -54.33% | -1,334.07% |
| Capital Expenditure | -7.45% | -23.04% | -48.66% | -29.36% | -39.77% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 100.00% | 100.00% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -17.67% | 13.86% | -39.98% | -38.10% | -38.28% |
| Cash from Investing | -26.86% | 10.72% | -53.66% | -47.24% | -47.61% |
| Total Debt Issued | -200.00% | -- | -- | -- | -- |
| Total Debt Repaid | 93.12% | 96.34% | 96.30% | 40.10% | -0.53% |
| Issuance of Common Stock | -47.83% | 1.89% | 40.43% | 22.81% | 13.11% |
| Repurchase of Common Stock | -- | 99.84% | -- | 100.00% | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 117.65% | 105.60% | 104.07% | 97.07% | 95.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 10.66% | 67.99% | -245.67% | -1,384.09% | -243.22% |